Co-Diagnostics, Inc. — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Co-Diagnostics, Inc. (market cap ~$10M) filed an 8-K on October 15, 2026, reporting Item 5.07 — submission of matters to a vote of security holders — for a vote held on October 14, 2026. The filing contains no substantive disclosure of what was voted on, vote counts, outcomes, or details of any proposals in the document excerpts provided.
Why this rating
Routine stockholder vote disclosure; no specifics on proposal, outcomes, or material business impact disclosed in filing extracts.
Extracted items
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.